Key Takeaways
- Demonstrates that disinfectant is effective in killing viruses in high risk environments such as medical areas.
- A 4 log reduction indicates that the disinfectant product can reduce the number of viruses by 99.99%
- According to EN 14476 passing criteria, 4 log reduction is the minimal efficacy requirement for a product to be considered “virucidal”
- As per EN 14476 testing guidelines, product is tested under defined contact times, soiled conditions and temperatures
- In the European market, a 4 log reduction is the accepted benchmark for products intended for medical use.
Summary
A 4 log reduction in EN 14476 testing means that the disinfectant can inactivate the viral pathogens by 99.99% under controlled laboratory conditions such as contact time, temperature, neutralization, soil load etc. 4 log reduction is the minimum efficacy criteria for disinfectant products intended to be used in medical areas.
What is 4 Log Reduction in EN 14476?
A 4 log reduction means the disinfectant is able to reduce viral pathogens by 99.99%. This is the minimum required level of efficacy for a product to be considered virucidal as per EN 14476 standard. It is one of the key benchmarks used in Europe to demonstrate that disinfectants actually work.
Log reduction scale explained
- 1 log means 90% reduction in the count of germs.
- 2 log means 99% reduction in the count of germs.
- 3 log means 99.9% reduction in the count of germs.
- 4 log means 99.99% reduction in the count of germs.
What is EN 14476?
EN 14476 is a Phase 2, Step 1 suspension test used to evaluate the virucidal activity for chemical disinfectants and antiseptics intended to be used in medical areas. It measures how effectively a product reduces viral infectivity under standardised lab conditions, covering both enveloped and non-enveloped viruses.
Why log reduction is a required benchmark
- Effective control of viral pathogens: A 4 log reduction ensures that the vast majority of viral particles are significantly reduced, which is critical in high-risk environments like hospitals and laboratories.
- Compliance with regulatory standards: Meeting this threshold allows manufacturers to make validated virucidal claims and align with European regulatory expectations.
- Ensuring public health safety: High efficacy levels help reduce transmission risks, especially during outbreaks of infectious diseases.
How EN 14476 test measures 4 log reduction
EN 14476 measures 4 log reduction using a quantitative suspension test under controlled, practical conditions.EN 14476 determines virucidal efficacy by comparing the infectious virus titre before and after exposure to a disinfectant under defined conditions.
Methodology overview
- A measured amount of virus suspension is prepared. This preparation is mixed with interfering substances.
- The disinfectant is then added to the mixture and allowed to act for a defined contact time.
- After the contact time, the mixture is neutralized to stop any further antiviral activity.
- Remaining infectious virus is measured and compared with the initial count
Result:
To pass EN 14476, the product shall achieve a ≥ 4 log reduction(99.99%)
Key factors that affect 4 log reduction results
- Contact time – Contact time is a critical parameter for achieving required reduction criteria. If the contact duration is too short, disinfectant product not be able to kill enough targeted viruses to achieve a 4 log reduction.
- Product concentration – The disinfectant becomes weak if it is overly diluted, this ultimately lowers concentration of active ingredients. It might not have the necessary antiviral action if it is weaker.
- Type of virus – Some viruses are more resistant than others. Compared to enveloped viruses, non-enveloped viruses are more difficult to kill.
- Temperature – Log reduction values are also temperature dependent. Lower or high temperatures can slow down interactions between disinfectant and microbes which can lessen the speed and efficacy of the disinfectant.
- Formulation stability – The active ingredients in the product may not work properly if formulation is not stable, which could lead to poor results.
When should companies test for EN 14476 compliance?
EN 14476 testing is required for disinfectant products intended for hospitals or medical areas
- During product development – To check if the formulation can actually achieve the required virucidal efficacy.
- Before making virucidal claims – Your product cannot be claimed “effective against viruses” without EN 14476 test data.
- Before entering the European market – EN 14476 testing is typically needed to support EU Biocidal Product Regulation(BPR) compliance.
- After formulation changes – Even small changes can affect the efficacy of the disinfectant. So re- testing is needed.
- When defining contact time claims – Product efficacy claims like 30 seconds or 1 minute must be validated under the same test conditions
Conclusion
4 log reduction requirement in EN 14476 is the precondition for disinfectants and antiseptics to be considered effective against enveloped and non-enveloped viruses. By adhering to this requirement, manufacturers can ensure their products are effective and meet the rigorous standards expected in Europe.
At Microbe Investigations Switzerland (MIS), we offer comprehensive EN 14476 testing services to ensure your antiviral products meet stringent international standards. From formulation development to final product validation, we provide comprehensive testing and certification to guarantee your products’ efficacy against viruses.
Contact us today to learn more about our EN 14476 testing services and how we can support your product development needs.
FAQs
1. What does 4 log reduction mean in EN 14476?
A 4 log10 reduction means a disinfectant reduces viral pathogens by upto 99.99%. This is the minimum efficacy criteria stipulated under EN 14476 guidelines.
2. Can a product pass EN 14476 with less than 4 log reduction?
No. Under EN 14476, a product must achieve at least a 4 log reduction in viral titre to be considered effective and pass the test.
3. Why are non-enveloped viruses harder to inactivate?
Non-enveloped viruses do not have a lipid envelope, making them less susceptible to many disinfectants.
4. What role does contact time play in achieving 4 log reduction?
Contact time plays an important role while evaluating the efficacy of virucidal disinfectants. .The disinfectant needs enough time to work on the virus, so it can be properly inactivated and achieve the required 4 log reduction.
5. Can formulation changes improve log reduction performance?
Yes. Small changes in concentration of the active ingredient or how they are combined can improve the log reduction performance of a product.
6. When should companies perform EN 14476 testing?
EN 14476 testing should be performed when developing or launching virucidal disinfectant products intended for healthcare or high-risk environments. It is required before market entry in Europe.
7. Is 4 log10 reduction required for all disinfectant standards?
No. The 4 log reduction requirement is especially for EN 14476 test standard. Other standards may use a different criteria depending on the type of microorganisms and intended use.
